What is dexa scan for bone density SEO Brief & AI Prompts

DEXA bone density is a dual‑energy X‑ray absorptiometry (DXA) scan that measures bone mineral density (BMD) in g/cm2 and reports a T‑score compared with a young‑adult reference, with the World Health Organization defining osteoporosis as a T‑score ≤ −2.5 and low bone mass (osteopenia) as T‑score between −1.0 and −2.5. The test typically images the lumbar spine and proximal femur and uses very low radiation (about 1–10 microsieverts), making it the standard bone mineral density test for diagnosing osteoporosis and monitoring therapy. Guideline screening commonly begins at age 65 in women and earlier for specific risk factors. Repeat testing intervals vary by risk and therapy.

DEXA uses two X‑ray beams at different energy levels to estimate BMD by comparing tissue absorption and producing site‑specific BMD values (lumbar spine, total hip, femoral neck) reported in g/cm2. International guidance from the International Society for Clinical Densitometry (ISCD) and the World Health Organization informs how to calculate and report T‑score and Z‑score; reference databases such as NHANES provide young‑adult means. Clinicians interpret a bone density test alongside tools like the FRAX fracture risk assessment to translate DEXA scan results into absolute 10‑year fracture probabilities. This combination of BMD and FRAX helps determine monitoring, pharmacotherapy, or evaluation for secondary causes. Machine calibration, positioning protocols, and vendor‑specific reference ranges affect DEXA scan interpretation and accuracy.

A common misconception is that a low T‑score alone mandates medication; guideline nuance matters. The U.S. Preventive Services Task Force recommends osteoporosis screening for women 65 and older and for younger women whose fracture risk equals or exceeds that of a 65‑year‑old white woman, while evidence is insufficient to recommend routine screening in men. The National Osteoporosis Foundation suggests treatment for adults with T‑score ≤ −2.5, and for those with low bone mass (T‑score −1.0 to −2.5) when FRAX estimates a 10‑year hip fracture risk ≥3% or major osteoporotic fracture ≥20%. For premenopausal adults and younger patients, the Z‑score guides DEXA scan interpretation and evaluation for secondary causes, such as glucocorticoid exposure. Example: a 60‑year‑old woman with T‑score −1.8 and FRAX hip risk 4% would meet treatment consideration per NOF.

Clinicians can use this information to align osteoporosis screening and management: order DEXA of the lumbar spine and hip for guideline‑indicated patients, report T‑score and Z‑score, calculate FRAX with femoral neck BMD when available, and evaluate secondary causes before starting pharmacotherapy. In men or younger adults with risk factors (long‑term glucocorticoids, prior low‑trauma fracture, hypogonadism, transplant), clinical judgment and endocrine or bone specialty consultation is appropriate. The following sections lay out a structured, step‑by‑step framework for ordering, interpreting, and acting on DEXA bone density results.